Kaposi's sarcoma at the University Teaching Hospital, Lusaka, Zambia in the antiretroviral therapy era.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Antiretroviral Therapy for HIV-Associated Cutaneous Kaposi's Sarcoma: Clinical, HIV-Related, and Sociodemographic Predictors of Outcome.AIDS research and human retroviruses · 2021
   Article
2. Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence.PloS one · 2021
   Article
3. Expression of CD40L on CD4Cancer treatment and research communications · 2021
   Article
4. Admitted AIDS-associated Kaposi sarcoma patients: Indications for admission and predictors of mortality.Medicine · 2020
   Observational
5. Comparative transcriptome analysis of endemic and epidemic Kaposi's sarcoma (KS) lesions and the secondary role of HIV-1 in KS pathogenesis.PLoS pathogens · 2020
   Article
6. Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
   Article
7. Cells of the Innate and Adaptive Immune Systems in Kaposi's Sarcoma.Journal of immunology research · 2020
   Review
8. Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.PloS one · 2020
   Article
9. Kaposi's sarcoma-associated herpesvirus protein ORF75 among HIV-1 patients in Kenya.African journal of laboratory medicine · 2020
   Article
10. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.The Journal of infectious diseases · 2019
    Article
11. Therapeutic Outcomes in AIDS-Associated Kaposi's Sarcoma Patients on Antiretroviral Therapy Treated with Chemotherapy at Two Tertiary Hospitals in Lusaka, Zambia.Current HIV research · 2018
    Article
12. Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
13. Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.Seminars in respiratory and critical care medicine · 2016
    Review
14. Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8.Pediatric blood & cancer · 2016
    Review
15. Epidemiology and transmission of Kaposi's sarcoma-associated herpesvirus.Viruses · 2014
    Review

Corrections and comments

• Commented on by
  HHV-8 seroprevalence in HIV-positive and HIV-negative populations.2015
• Comment on
  Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.2014

Authors and funding

3 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as